Tofaom (Tofacitinib 5mg) Tablets – JAK Inhibitor for Rheumatoid & Autoimmune Dis

Tofaom (Tofacitinib 5mg) Tablets is an advanced targeted oral therapy designed for the management of autoimmune inflammatory conditions. As a Janus kinase (JAK) inhibitor, it works by blocking intracellular signaling pathways responsible for inflammation and immune response.

By modulating cytokine activity, Tofacitinib helps reduce joint pain, swelling, and stiffness while slowing disease progression. It improves physical function and quality of life, making it a valuable option for patients who have an inadequate response to conventional therapies.

Key Benefits

• Targeted JAK inhibitor for autoimmune conditions

• Reduces joint pain, swelling, and inflammation

• Improves mobility and physical function

• Slows progression of joint damage

• Convenient oral therapy alternative to injectables

• Enhances overall quality of life

Indications

• Rheumatoid arthritis

• Psoriatic arthritis

• Ankylosing spondylitis (as per physician discretion)

• Moderate to severe active inflammatory disease

• Patients with inadequate response to conventional therapy